155 results on '"Maron, Martin S."'
Search Results
2. Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy
3. Abstract 13383: Is Genotype Negative Hypertrophic Cardiomyopathy Really Benign? The Increased Risk of Sudden Death and Advanced Heart Failure in the Absence of Pathogenic Sarcomere Mutations
4. Abstract 13312: Can the Extent of Late Gadolinium Enhancement on Cardiac Magnetic Resonance Be Predicted by the 12-Lead Electrocardiogram?
5. Abstract 11009: A Novel Patient-Patient Network Medicine Approach to Refine Hypertrophic Cardiomyopathy Subgrouping: Implications for Risk Stratification
6. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
7. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
8. Abstract 17402: Single Nuclei RNA-sequencing of Human Hypertrophic Cardiomyopathy Myectomy Samples Reveals Common Novel Mechanisms of Pathogenesis and Potential Therapeutic Targets Regardless of Genotype
9. Abstract 17341: Obesity is Associated With Progressive Heart Failure in Hypertrophic Cardiomyopathy
10. Abstract 16082: Machine Learning to Improve Left Ventricular Scar Quantification in Hypertrophic Cardiomyopathy Patients
11. Abstract 15961: Multicenter Prospective Prevention of Sudden Death in High Risk Patients Utilizing Enhanced ACC/AHA Risk Model
12. Abstract 15889: The Role of Physical Deconditioning in Distinguishing Hypertrophic Cardiomyopathy From Athleteʼs Heart
13. Abstract 13590: Demographic and Clinical Characteristics of Patients With Obstructive Hypertrophic Cardiomyopathy in a Large, Nationwide Us Cohort
14. Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy
15. Response by Rowin et al to Letter Regarding Article, “Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy”
16. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy
17. Abstract 13853: A Fully Automated Deep Phenotyping of Late Gadolinium Enhancement Cardiac MRI for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
18. Abstract 12234: Is Maintenance of a Subcutaneous Implantable Cardioverter-Defibrillator a Feasible Option in Hypertrophic Cardiomyopathy Patients With Left Bundle Branch Block After Septal Myectomy?
19. Abstract 12221: Reduction of Inappropriate Shocks Over Time in Hypertrophic Cardiomyopathy Patients With Subcutaneous Implantable Cardioverter-Defibrillators
20. Abstract 9544: Physical Activity in Individuals With Hypertrophic Cardiomyopathy: Baseline Data From the Prospective "Lifestyle and Exercise in Hcm" (live-hcm) Study
21. Abstract 9615: Predictors of Impedance During Subcutaneous ICD Defibrillation Testing in Hypertrophic Cardiomyopathy
22. Abstract 9755: Impact of Outflow Obstruction and Septal Myectomy on Long Term Risk of New Onset Atrial Fibrillation in Hypertrophic Cardiomyopathy
23. Exploring New and Old Therapies for Obstructive Hypertrophic Cardiomyopathy
24. Letter by Maron et al Regarding Article, “Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)”
25. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
26. Case for Earlier Surgical Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy
27. Association Between Race and Clinical Profile of Patients Referred for Hypertrophic Cardiomyopathy
28. Perspectives on the Overall Risks of Living With Hypertrophic Cardiomyopathy
29. Response to Letter Regarding Article, “Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy”
30. Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies
31. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact
32. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes
33. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis
34. Abstract 16551: Pathways of Prognosis and Effective Treatment Interventions in Hypertrophic Cardiomyopathy
35. Abstract 13977: Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction
36. Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy
37. Abstract 18019: Successful Surgical Management of Severely Symptomatic Hypertrophic Cardiomyopathy Patients With Minimal Septal Hypertrophy
38. Abstract 14017: Contemporary Management Strategies Provide Low Mortality Rates for Young Patients with Hypertrophic Cardiomyopathy
39. Abstract 14647: Stress Echocardiography Predicts Heart Failure Progression and Alters Management Strategies in Patients with Hypertrophic Cardiomyopathy
40. Abstract 13943: Hypertrophic Cardiomyopathy with Left Ventricular Apical Aneurysm Represents a High-Risk Subgroup Necessitating Aggressive Preventive Therapy: A Long-term Follow-Up Study
41. Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
42. Risk Stratification and Outcome of Patients With Hypertrophic Cardiomyopathy ≥60 Years of Age
43. A Paradigm Shift in Our Understanding of the Development of the Hypertrophic Cardiomyopathy Phenotype?
44. Abstract 13139: Prognostic Utility of Contrast-Enhanced Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy: An International Multicenter Study
45. Abstract 8115: Circadian Rhythm Pattern of Events in Tako-tsubo Cardiomyopathy
46. Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy
47. Adipositas Cordis
48. Research Priorities in Hypertrophic Cardiomyopathy
49. Utility of Cardiovascular Magnetic Resonance in the Diagnosis of Anderson-Fabry Disease
50. Overlapping Phenotypes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.